Videos

Cancer cells

Vodcast: Dennis Brown, Kintara Therapeutics, at AACR 2023

31 August 2023

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. In this vodcast episode, Thomas speaks with Dennis Brown, Chief Scientific Officer at Kintara Therapeutics. You can read or listen to a […]

""

Listicle: Three data problems solved by a connected lab

13 July 2023

In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform.  How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team Edition is a cloud platform where teams […]

Listicle: Five tips on scaling up IVT for mRNA production

14 March 2023

In this listicle, Thermo Fisher Scientific outlines five measures to help you ensure consistency in your workflow and produce reproducible, high-quality batches of IVT mRNA at scale. The success of messenger RNA (mRNA) vaccines in combatting the global SARS-CoV-2 crisis brings a new era of vaccine development. Applications of in vitro transcribed (IVT) RNA in […]

Vodcast: Avacta Group Open Day 2022

3 November 2022

Clinical stage oncology company Avacta Group has moved its Therapeutics division to a new headquarters at Scale Space in Imperial College’s White City Campus, London. DDW Multimedia Editor Megan Thomas attended the open day to learn more about the company’s intentions. In this video, she speaks to Neil Bell, Chief Development Officer at Avacta and […]

Listicle: Maximising outsourcing models beyond time and cost

28 September 2022

Challenges in outsourcing drug discovery In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring.   The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Many companies have several projects ongoing simultaneously, […]

Listicle: Selecting the best gene delivery method

7 June 2022

 Mirus Bio outlines when to use transfection reagents, viral transduction or electroporation   No single delivery method is ideal for all situations, but researchers may routinely employ a suboptimal approach for the sake of familiarity or to avoid any start-up costs associated with new methods.   The uses of nucleic acid delivery have expanded from recombinant […]

Listicle: Driving production in biologics with automation 

4 May 2022

Drug development technology has evolved rapidly in recent years, and with the industry advancement comes an increased capability of producing high-quality targeted large molecule drugs such as biologics and biosimilars. The significance of biologics is far-reaching, including treatment of rheumatologic diseases, cancer, diabetes and anaemia. The range of therapy modalities is ever-expanding and at present […]

Listicle: Lithuania’s biotechnology growth strategy

3 March 2022

Lithuania is dedicating time and resources establishing itself as a life science and biotechnology hub of excellence. DDW’s Megan Thomas analyses four pillars of Lithuania’s growth strategy, which involves ensuring female scientists take leading roles in industry, focusing on investment, developing a strong talent pool as well establishing itself as a go-to destination for clinical trials. […]

PerkinElmer Informatics helps chemists gain insights into structure and sequence activity 

1 February 2022

Signals Inventa is a next-generation data management system for the analysis of scientific results. PerkinElmer has released a video that explains how this platform works.   The video shares how Signals Inventa provides a faster way to help chemists gain insights into structure and sequence activity relationships through a guided search and analysis workflow that […]

Developing pain medication with fewer side effects 

3 December 2021

Dr. Ken Ng, a professor at the University of Windsor and adjunct professor at the University of Calgary (UCalgary), and Sam Carr, a PhD student from UCalgary, have been working with Dr. Peter Facchini’s group at UCalgary to better understand how natural opiates are produced. The team has narrowed their focus on one enzyme in the last stage of […]

Closing drug development gaps with new clinical prediction AI 

1 December 2021

Quris, an artificial intelligence (AI) company in the pharmaceutical industry, has launched a clinical prediction AI platform to predict which drug candidates will safely work in humans. This will improve efficacy and cut drug development costs.   What do they do?  Quris uses AI-powered miniaturised “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate […]

Listicle: Experts on the differences between FDA and EMA regulations

6 October 2021

Biotechs involved in drug discovery have to navigate increasingly complex regulatory environments across borders. Experienced experts and non-executive advisors to Arriello, Eric Caugant, Principal Consultant at Pharmacovigilance Systems Consulting & Board advisor to Arriello, and Judi Sills, JM Sills Consulting & Board advisor to Arriello, highlight the main differences between US and EU requirements, and advise on […]

Protein-protein Interactions Using NanoBRET Technology

20 August 2021

In this video, Dr Gary Allenby, CEO Aurelia Bioscience, describes a scientific poster on ‘Protein-protein Interactions Using NanoBRET Technology’. Historically, only solution-based assays were used to screen compounds in PPI, but a more physiological approach is to examine the interaction in living cells. However, there are very few commercially available technologies that can actually do […]

Micro Tissues on Electrospun Scaffolds

29 July 2021

In this video, Dr Gary Allenby, CEO Aurelia Bioscience, describes a scientific poster on ‘Magnetic Electrospun Micro-fibre Scaffold Assemblies: Examples of their use for 3-Dimensional Cell-Based Screening Applications’. How the technology works: Aurelia Bioscience has developed a 3-D micro-tissue system from electrospun material that can be used in conjunction with well plates for higher throughput […]

The gel-free, blot-free, hands-free reinvention of western blotting

22 June 2021

Aurelia Bioscience, a Nottingham, UK based pre-clinical Contract Research Organisation (CRO) has produced a video to explain the functioning of WES and JESS – two highly reproducible, capillary based, automated western blot instruments from ProteinSimple: Whilst traditional western blotting typically runs 10-20 samples in three to five hours and requires 24-48 hours to produce results; […]

Re-energise your kinase discovery programme

9 June 2021

Using Promega’s NanoBRET technology, scientists at Aurelia Bioscience have implemented intracellular kinase assays designed to study the interaction of compounds on kinase targets in intact living cells. Advantages of this technique include examination of compound binding to target kinases at physiological ATP concentrations, expression of full-length kinase target in cells, disruption of cells (with digitonin) […]

Next »